Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/23/2023 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 9.3k | $3.28 | $30.6k | | 03/23/2023 |
03/23/2023 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 9.7k | $2.86 | $27.7k | | 03/23/2023 |
01/03/2023 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 10k | $2.66 | $26.6k | | 01/03/2023 |
06/22/2022 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 40k | $1.82 | $72.8k | | 06/22/2022 |
01/03/2022 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 10k | $12.28 | $122.8k | | 01/03/2022 |
11/16/2021 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 1.4k | $18.02 | $24.5k | | 11/15/2021 |
11/16/2021 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 1.4k | $2.86 | $3.9k | | 11/15/2021 |
11/15/2021 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 18.8k | $2.86 | $53.8k | | 11/15/2021 |
11/15/2021 | Cue Biopharma, Inc. | CUE | Sale | Common Stock | 18.8k | $17.92 | $337.2k | | 11/15/2021 |
06/25/2021 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 40k | $4.00 | $160k | | 06/25/2021 |
01/04/2021 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 10k | $12.36 | $123.6k | | 01/04/2021 |
06/23/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Options (Right to buy) | 40k | $3.27 | $130.8k | | 06/23/2020 |
01/25/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $3.23 | $64.6k | | 01/25/2020 |
01/02/2020 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 8k | $16.31 | $130.5k | | 01/02/2020 |
01/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $2.74 | $54.8k | | 01/25/2019 |
01/02/2019 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 8k | $5.16 | $41.3k | | 01/02/2019 |
10/24/2018 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 30k | $4.46 | $133.8k | | 10/24/2018 |
06/12/2018 | Cue Biopharma, Inc. | CUE | Exercise | Stock Option (right to buy) | 9.6k | $14.24 | $136.7k | | 06/12/2018 |
02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Common Stock, Class A | 44.9k | $18.00 | $807.4k | | 02/13/2018 |
02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Stock Option (right to buy) | 250k | $8.33 | $2.1M | | 02/13/2018 |
02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Stock Option (right to buy) | 38.5k | $14.82 | $570.6k | | 02/13/2018 |
02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Stock Option (right to buy) | 87.2k | $13.80 | $1.2M | | 02/13/2018 |
02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Stock Option (right to buy) | 133k | $11.85 | $1.6M | | 02/13/2018 |
12/31/2017 | Sucampo Pharmaceuticals, Inc. | SCMP | Grant | | 329 | $9.10 | $3k | | 12/31/2017 |
12/28/2017 | Sucampo Pharmaceuticals, Inc. | SCMP | Payment of Exercise | Common Stock, Class A | 27.5k | $17.98 | $494.4k | | 12/28/2017 |
12/07/2017 | Sucampo Pharmaceuticals, Inc. | SCMP | Exercise | Employee Stock Option (right to buy) | 50k | $8.33 | $416.5k | | 12/07/2017 |
12/07/2017 | Sucampo Pharmaceuticals, Inc. | SCMP | Sale | Common Stock, Class A | 50k | $16.50 | $825k | | 12/07/2017 |
06/30/2017 | Sucampo Pharmaceuticals, Inc. | SCMP | Grant | | 336 | $8.93 | $3k | | 06/30/2017 |